Tango Therapeutics (BCTG Acquisition) ^{Priced, Nasdaq: TNGX}

We are a newly organized blank check company. Our sponsor is an affiliate of Boxer Capital, a private biopharmaceutical investment firm based in San Diego, California. Our strategy is to leverage our management team’s expertise and network of key opinion leaders, expert consultants, healthcare executives, biotechnology investors and investment bankers to identify and acquire an attractive target business in the biotechnology industry. We believe that Boxer Capital’s reputation and track record of favorable investments are an additional competitive advantage that will make us an attractive partner for companies in this competitive environment. In addition to identifying and capitalizing an attractive target, we believe that the sector expertise and broad relationship network of our management team and board of directors will allow them to add significant value after consummation of an initial transaction by (1) providing strategic guidance on clinical development, competitive positioning, financing and partnerships, (2) assisting in the recruitment of key executives, (3) providing an investor perspective on market information and investor relations and (4) corporate governance and public company readiness.